Condition: Disseminated Histoplasma Capsulatum Infection · AIDS and Infections · Immunosuppression · Sponsor: Federal University of Health Science of Porto Alegre
Phase III trial evaluating the safety and efficacy of a single high dose (10 mg/kg) of liposomal amphotericin B for disseminated histoplasmosis in AIDS patients, in comparison to standard therapy (3 mg/kg of liposomal amphotericin B for two weeks) (INDUCTION trial).
This description comes directly from the study's public registry record.
Alessandro C Pasqualotto, MD PhD · +5551999951614 · acpasqualotto@hotmail.com
Diego R Falci, MD PhD · +5551997507835 · diego.falci@gmail.com
Always discuss trial participation with your own doctor first.
| Hospital de Doenças Tropicais | Goiânia, Goiás, Brazil | Recruiting |
| Hospital Giselda Trigueiro | Natal, Rio Grande do Norte, Brazil | Recruiting |
| Federal University of Health Sciences of Porto Alegre | Porto Alegre, Rio Grande do Sul, Brazil | Recruiting |
| Hospital de Clinicas de Porto Alegre | Porto Alegre, Rio Grande do Sul, Brazil | Recruiting |
| Hospital Geral de Roraima | Boa Vista, Roraima, Brazil | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05814432